What is PT-141?
The US National Library of Medicine lists PT-141 as an entry term for bremelanotide. That terminology connection explains why a PT-141 reference may lead to Vyleesi, a specifically named bremelanotide medicine. It does not make the catalogue's PT-141 10MG vial an authenticated Vyleesi presentation. NLM bremelanotide terminology record, Vyleesi prescribing information.
The vial's 10MG is a catalogue amount, not a concentration or a use instruction. Terminology and medicine identity are separate: a shared substance term does not independently establish formulation, quality or equivalence to the labeled product. NLM bremelanotide terminology record.
What is Vyleesi approved for?
Vyleesi's US label limits its indication to premenopausal women with acquired, generalized hypoactive sexual desire disorder, under the label's listed diagnostic conditions. Vyleesi prescribing information.
The label expressly states that Vyleesi is not indicated to enhance sexual performance. This is an important distinction when interpreting PT-141 descriptions: the named medicine's restricted disorder-related indication cannot be rewritten as a general performance claim, or transferred to the supplier vial. Vyleesi prescribing information.
Bremelanotide side effects and cardiovascular warnings
Vyleesi is contraindicated in patients with uncontrolled hypertension or known cardiovascular disease. Its label also warns of transient increases in blood pressure and reductions in heart rate. These are specific restrictions and effects described for the named medicine, rather than evidence that the catalogue vial has been assessed in the same way. Vyleesi prescribing information.
Nausea is listed among Vyleesi's most common adverse reactions. It neither authenticates a supplier product nor establishes that a PT-141 amount field has a clinical meaning equivalent to the medicine label. Vyleesi prescribing information.
The separate PT-141 10mg Pen allows a comparison of catalogue formats. Its name and nominal amount do not change the bremelanotide terminology link into evidence of Vyleesi equivalence. NLM bremelanotide terminology record.
